Courage Capital Management LLC Intellia Therapeutics, Inc. Transaction History

Courage Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $153,960 - $304,840	-4,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$60.88 - $161.91 $121,760 - $323,820	-2,000 Reduced 33.33%	4,000 $648,000
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $112,979 - $381,180	6,000 New	6,000 $326,000
Q4 2018 Feb 14, 2019	SELL	$11.39 - $27.13 $79,730 - $189,910	-7,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$25.78 - $32.6 $226,864 - $286,880	-8,800 Reduced 55.7%	7,000 $200,000
Q2 2018 Aug 14, 2018	BUY	$20.02 - $30.79 $316,316 - $486,482	15,800 New	15,800 $432,000
Q1 2018 May 14, 2018	SELL	$19.43 - $34.95 $139,896 - $251,640	-7,200 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$17.39 - $31.12 $125,208 - $224,064	7,200	7,200 $138,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Courage Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Courage Capital Management LLC with notifications on news.